Abstract
The coordinated terrorist attacks on October 7, 2023, resulted in catastrophic atrocities, and marked the beginning of the 2023 Israel–Hamas war. The overwhelming coverage by mainstream and social media, characterized by extreme details and graphic images, vividly transported viewers to the horrifying scene. It remains unclear to what extent such indirect exposure influences the occurrence of stress, anxiety, and post-traumatic symptoms. We analyzed data from a three-year prospective study in which 4,797 participants received smartwatches and completed daily questionnaires, supplemented by a nationwide clinical survey with 2,536 participants. Among the participants not directly exposed, we estimated PTSD prevalence to be 22.9-36.0% and moderate to severe anxiety prevalence to be 22.9-55.32%, with 752,057 daily questionnaires before and after October 7 further indicating higher stress levels than those reported in previous events, including political disputes, the COVID-19 pandemic, and past armed conflicts. The occurrences of PTSD and anxiety are well explained by increased and persistent news consumption, and especially by the availability of gory videos on social media. Continuous monitoring of participants via smartwatches and daily questionnaires further revealed considerable differences in stress, mood, step counts, sleep quality, and duration in the first week after the October 7 events among those who later developed PTSD. This study demonstrates the unprecedented amplifying effect of mass media on mental health in terror and war settings and highlights the potential of continuous monitoring for early detection and prompt treatment of those in need.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by ISRAEL SCIENCE FOUNDATION (grant no. 3409/19), within the Israel Precision Medicine Partnership program and a Koret Foundation gift for Smart Cities and Digital Living.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The panel study, PTSD survey, and the prospective study protocols were approved by the Tel Aviv University Institutional Review Board (0007545-1). Before participating in the panel studies, all subjects were advised, in writing, as to the nature of the study. All data were de-identified and no personally identifiable information was gathered.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
